New pharmaceutical target reverses osteoporosis in mice: Duke researchers show that activating the adenosine receptor A2B not only halts but reverses bone deterioration in mouse models of osteoporosis
Read More About This Article: https://ift.tt/2HjsqkS
No comments :
Post a Comment